Trump has a golden opportunity to stick it to the international freeloaders who've been riding America's coattails on medical ...

Regulatory reforms that improve the competitive landscape for biosimilars will promote drug affordability while incentivizing ...

A much-anticipated meeting between President Donald Trump and representatives of the pharmaceutical industry took place ...

To support the implementation of DPCO, 2013, the Integrated Pharmaceutical Database Management System (IPDMS) was developed.

Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare ...

Three senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to disclose what he and President ...

NPPA has over the past decade introduced price controls on all essential drugs that are used to treat or manage non-communicable diseases such as cardiovascular diseases, chronic respiratory ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.

Sri Lanka will expand the current administered prices to 862 drugs in the market, Health Minister Nalinda Jayatissa said ...